细胞因子在肺动脉高压发病中作用的研究进展

doi:10.3969/j.issn.1000-8535.2016.02.035

广州医药 ›› 2016, Vol. 47 ›› Issue (2): 100-102.DOI: 10.3969/j.issn.1000-8535.2016.02.035

• 综述 • 上一篇

细胞因子在肺动脉高压发病中作用的研究进展

欧东, 贺仁忠

遵义医学院附属医院呼吸二科 (贵州 563000)

收稿日期:2015-11-12 出版日期:2016-03-20 发布日期:2021-11-30
通讯作者: 贺仁忠,E-mail :renzhonghe914@163.com

Research progress of cytokines in the pathogenesis of pulmonary hypertension

Ou Dong

Zunyi Medical College, Guizhou 563003, China He Ronzhong. Two Department of Respilatory of Affiliated Hospital of Zhuyi Medical Colleye, Guizhou 563000, China

Received:2015-11-12 Online:2016-03-20 Published:2021-11-30

摘要/Abstract

摘要： 肺动脉高压是一类发病率低,但常引起右心衰竭等最终导致患者死亡的严重肺血管疾病,其形成的主要病理改变是肺血管重构和肺血管收缩,多种细胞因子异常作用参与发病,对该作用机制的研究成为了治疗疾病,改善疾病预后的关键。

关键词: 肺动脉高压, 细胞因子, 肺血管重塑, 肺血管收缩

Abstract: Pulmonary hypertension is a kind of low incidence, but it is often caused by right heart failure and other serious pulmonary vascular disease. The main pathological changes of pulmonary vascular include remodeling and pulmonary vascular contraction, and many kinds of cytokines are involved in the pathogenesis of disease, which is the key to improve the prognosis of the disease.

Key words: Pulmonary arteria l hypertension, Cell factor, Pulmonary vascular remodeling, Pulmonary blood vessel contraction

欧东, 贺仁忠. 细胞因子在肺动脉高压发病中作用的研究进展[J]. 广州医药, 2016, 47(2): 100-102.

Ou Dong. Research progress of cytokines in the pathogenesis of pulmonary hypertension[J]. Guangzhou Medical Journal, 2016, 47(2): 100-102.

参考文献

[1] MONTANI D, GÜNTHER S, DORFMÜLLEr P, et al. Pulmonary arterial hypertension[J].Orphanet J Rare Dis, 2013, 8(1): 97-101.
[2] ZENG Y, LIU H, KANG K, et al. Hypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells[J].Scientific reports, 2015, 5: 12098.
[3] PISARCIK S, MAYLOR J, LU W, et al.Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1[J]. American Journal of Physiology-Lung Cellular and Molecular Physiology, 2013, 304(8): L549-L561.
[4] WANG J, FU X, YANG K, et al. Hypoxia inducible factor 1 dependent upregulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs[J].Cardiovascular research, 2015: cvv122.
[5] LIU R, WU S, CAO G, et al. Transfection of human hepatocyte growth factor gene inhibits advancing pulmonary arterial hypertension induced by shunt flow in a rabbit model[C]. Transplantation proceedings. Elsevier, 2013, 45(2): 705-712.
[6] 周英, 王乐, 李明霞,等. 缺氧诱导因子-1α及其内皮素-1、肾上腺髓质素在缺氧性肺动脉高压新生大鼠中的变化[J].中华实用儿科临床杂志, 2013, 28(18):1384-1389.
[7] CAMPIA U, MATUSKEY LA, TESAURO M, et al. PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia[J].Atherosclerosis, 2014, 234(2): 436-440.
[8] FERRER E, PEINADO VI, CASTAÑEDA J, et al. Effects of cigarette smoke and hypoxia on pulmonary circulation in the guinea pig[J].European Respiratory Journal, 2011, 38(3): 617-627.
[9] RITA DE CASSIA SF, MONTENEGRO SML, DOMIN-GUES ALC, et al. TGF beta and IL13 in schistosomiasis mansoni associated pulmonary arterial hypertension; a descriptive study with comparative groups[J].BMC infectious diseases, 2014, 14(1): 282.
[10] 朱诗平, 孙升云, 冯伟峰, 等. 氯沙坦对肾间质纤维化大鼠肾组织 ACE2mRNA, TGF-β1mRNA 表达的影响[J].中国老年学杂志, 2012, 32(5): 968-971.
[11] VOELKEL NF, GOMEZ-ARROYO J. The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox[J].American journal of respiratory cell and molecular biology, 2014, 51(4): 474-484.
[12] SCHAD JF, MELTZER KR, HICKS MR, et al. Cyclic strain upregulates VEGF and attenuates proliferation of vascular smooth muscle cells[J].Vasc Cell, 2011, 3: 21.
[13] STAR GP, GIOVINAZZO M, LAMOUREUXE, et al. Effects of vascular endothelial growth factor on endothelin-1 production by human lung microvascular endothelial cells in vitro[J].Life sciences, 2014, 118(2): 191-194.
[14] PRICE LC, WORT SJ, PERROS F, et al. Inflammation in pulmonary arterial hypertension[J].Chest Journal, 2012, 141(1): 210-221.
[15] HIRAMINE K, SATA N, IDO A, et al. Hepatocyte growth factor improves the survival of rats with pulmonary arterial hypertension via the amelioration of pulmonary hemodynamics[J].International journal ofolecular medicine, 2011, 27(4): 497-502.
[16] SHIMODA LA, LAURIE SS, Vascular remodeling in pulmonary hyper-tension[J].Journal of Molecular Medicine,2013, 91(3): 297 -309.
[17] LIU B, WANG XM, ZHOU TF, et al. Expression of connective tissue growth factor and its down-regulation by simvastatin administration in pulmonary hypertensive rats[J]. Chinese journal of pediatrics, 2008, 46(5): 359-365.

细胞因子在肺动脉高压发病中作用的研究进展

Research progress of cytokines in the pathogenesis of pulmonary hypertension

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

本文评价

[1]	闫利辉, 姚海亮, 刘琳, 张娴, 谢冰. 牙周基础治疗联合口腔正畸对牙周炎患者炎症细胞因子的疗效分析[J]. 广州医药, 2021, 52(5): 122-126.
[2]	翟子敬, 秦文娟, 王臻, 郭雪婷, 王忠, 芦桂林. 探讨肺动脉高压大鼠心肌损伤与氧化应激损伤的相关性研究[J]. 广州医药, 2021, 52(1): 1-5.
[3]	杜碧君, 王晨虹. 细胞因子在妊娠期亚临床甲减患者不良妊娠结局中的作用[J]. 广州医药, 2020, 51(6): 101-104.
[4]	陈泳华, 曾军, 刘春丽, 王健. COPD合并肺动脉高压疾病危险因素分析[J]. 广州医药, 2018, 49(5): 74-77.
[5]	文昌晖. 白癜风初诊患者外周血细胞因子水平与临床分型、皮损面积的相关性研究[J]. 广州医药, 2016, 47(3): 33-35.
[6]	谢轶群. 细胞因子与支气管哮喘[J]. 广州医药, 2016, 47(2): 96-99.